Related Experiment Video
Updated: Jul 18, 2026
08:07
Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test
Published on: November 23, 2019
Minimal clinically important differences in the six-minute walk test and the incremental shuttle walking test
Robert A Wise1, Cynthia D Brown
1Division of Pulmonary and Critical Care Medicine, Johns Hopkins Asthma and Allergy Center, Johns Hopkins University School of Medicine, 4B. 72, 5501 Hopkins Bayview Circle, Baltimore, Maryland 21224, USA. rwise@jhmi.edu
COPD
|December 2, 2006
Summary
Simple walking tests like the 6-minute walking test (6MWT) and incremental shuttle walking test (SWT) assess functional status in COPD patients. The 6MWT has established minimal clinically important differences, while SWT needs further validation.
Area of Science:
- Pulmonary Medicine
- Clinical Exercise Physiology
Background:
- Simple walking tests are crucial for assessing functional status in cardiorespiratory disorders, particularly Chronic Obstructive Pulmonary Disease (COPD).
- Standardization is essential for reproducible results in these less instrumented tests compared to formal cardiopulmonary exercise tests.
Purpose of the Study:
- To review the characteristics and clinical utility of the 6-minute walking test (6MWT) and the incremental shuttle walking test (SWT) in COPD patients.
- To discuss the minimal clinically important difference (MCID) for the 6MWT and the need for similar data for the SWT.
- To highlight considerations for interpreting clinical trial data in COPD.
Main Methods:
- Review of existing literature on the 6-minute walking test (6MWT) and incremental shuttle walking test (SWT) in COPD.
- Analysis of data regarding reproducibility, responsivity, and correlation with other health metrics.
- Examination of studies defining the minimal clinically important difference (MCID).
Main Results:
- The 6MWT is well-characterized in COPD, with results correlating to pulmonary function, quality of life, exercise capacity, and mortality.
- The minimal clinically important difference (MCID) for the 6MWT is estimated at 54-80 meters; a change of 86 meters is needed for statistical confidence.
- The SWT shows similar reproducibility (CV ≈ 20%) and improves with interventions, correlating with maximal oxygen consumption, but lacks MCID studies.
Conclusions:
- The 6MWT is a validated tool for assessing COPD functional status with established MCID.
- Further research is needed to establish the MCID for the SWT.
- Clinical trial design for COPD should consider factors beyond MCID, including baseline severity and treatment asymmetry.
